HIV Management

To better understand immune reconstitution in children with HIV taking antiretroviral therapy, researchers compared immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in...

After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.

While neurocognition can increasingly decline with age among individuals with HIV, researchers of a study presented at CROI 2019 determined which factors are connected with neurocognitive decline in the...

As effective HIV interventions have been identified, the design and interpretation of HIV prevention trials has evolved. David Dunn, from University College London, explained these changes during CROI...

Researchers designed a survey to determine whether pregnant women with HIV knew their partner’s HIV status, their prevention or treatment plan, and if they had health insurance.

Given that the prevalence of obesity is increasing among people liv

In a new study presented at IDWeek 2018, researchers examined the effect of required patient consent prior to HIV and HCV screening.

In this study, the researchers examined adipose tissue changes of men with HIV who were taking cART to determine whether diagnosing metabolic syndrome rather than lipodystrophy is better for cardiometabolic...

Although isoniazid is safe for adults with HIV, its effects in children are unknown. A new review aimed to better understand these effects.

In a new study, researchers examined whether HIV is independently associated with abdominal obesity, elevated LDL-C, hypertriglyceridemia, and hypertension.